What is the difference between Mounjaro and Rybelsus?
Mounjaro is tirzepatide (GIP/GLP-1 dual receptor agonist) and Rybelsus is semaglutide (oral) (GLP-1 receptor agonist (oral tablet)). They have different active ingredients and slightly different side-effect profiles.
Is Mounjaro or Rybelsus more effective for weight loss?
Head-to-head trial data favors tirzepatide-based medications (Mounjaro, Zepbound) over semaglutide-based medications (Ozempic, Wegovy) in average percent weight loss. SURMOUNT-1 reported ~20.9% mean weight loss on tirzepatide 15 mg; STEP 1 reported ~14.9% on semaglutide 2.4 mg over comparable timelines.
Can I switch between Mounjaro and Rybelsus?
Switching between GLP-1 medications requires re-titration when crossing active ingredients (semaglutide β tirzepatide). Always coordinate with your prescriber before switching.